ZILXI Drug Patent Profile

✉ Email this page to a colleague

When do Zilxi patents expire, and what generic alternatives are available?

Zilxi is a drug marketed by Journey and is included in one NDA. There are eight patents protecting this drug and one Paragraph IV challenge.

This drug has twenty-two patent family members in ten countries.

The generic ingredient in ZILXI is minocycline hydrochloride. There are fifteen drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the minocycline hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Zilxi

A generic version of ZILXI was approved as minocycline hydrochloride by WATSON LABS on December 30^th, 1991.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for ZILXI?
What are the global sales for ZILXI?
What is Average Wholesale Price for ZILXI?

Summary for ZILXI

International Patents:	22
US Patents:	8
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	95
Patent Applications:	2,826
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for ZILXI
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for ZILXI
What excipients (inactive ingredients) are in ZILXI?	ZILXI excipients list
DailyMed Link:	ZILXI at DailyMed

Drug patent expirations by year for ZILXI

Pharmacology for ZILXI

Drug Class	Tetracycline-class Drug
Physiological Effect	Decreased Prothrombin Activity

Paragraph IV (Patent) Challenges for ZILXI

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
ZILXI	Topical Aerosol Foam	minocycline hydrochloride	1.50%	213690	1	2022-02-28

US Patents and Regulatory Information for ZILXI

ZILXI is protected by eight US patents.

Patents protecting ZILXI

Topical tetracycline compositions
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA.

Compositions, gels and foams with rheology modulators and uses thereof
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Topical tetracycline compositions
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA.

Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA.

Topical tetracycline compositions
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA.

Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Topical tetracycline compositions
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA.

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Journey	ZILXI	minocycline hydrochloride	AEROSOL, FOAM;TOPICAL	213690-001	May 28, 2020		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Journey	ZILXI	minocycline hydrochloride	AEROSOL, FOAM;TOPICAL	213690-001	May 28, 2020		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Journey	ZILXI	minocycline hydrochloride	AEROSOL, FOAM;TOPICAL	213690-001	May 28, 2020		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Journey	ZILXI	minocycline hydrochloride	AEROSOL, FOAM;TOPICAL	213690-001	May 28, 2020		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for ZILXI

See the table below for patents covering ZILXI around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
World Intellectual Property Organization (WIPO)	2011138678		⤷ Sign Up
Brazil	112012007473	composições tópicas de tetraciclina e respectivo método de uso	⤷ Sign Up
Mexico	2012003985	COMPOSICIONES TOPICAS TETRACICLINA. (TOPICAL TETRACYCLINE COMPOSITIONS.)	⤷ Sign Up
Canada	2776366	COMPOSITIONS MOUSSANTES SANS EAU ET SANS SURFACTANT, MOUSSES ET GELS FRIABLES, AINSI QUE LEURS UTILISATIONS (SURFACTANT-FREE WATER-FREE FOAMABLE COMPOSITIONS, BREAKABLE FOAMS AND GELS AND THEIR USES)	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for ZILXI

Pharmacology for ZILXI

Paragraph IV (Patent) Challenges for ZILXI

Patents protecting ZILXI

Make Better Decisions: Try a trial or see plans & pricing